Editorial [Hot Topic: Overview of Antiangiogenic Therapies in Hematological Malignancies (Guest Editor: D. Ribatti)]

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|11|9|995-996

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.11, Iss.9, 2011-11, pp. : 995-996

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [Hot Topic: Antiangiogenesis in Chronic Inflammation (Guest Editor: Domenico Ribatti)]

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 1, 2005-02 ,pp. : 1-1

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Innovative Therapeutical Approaches for Hematological Malignancies Based on Molecular Targeted Therapies (Executive Editor: Giorgio Zauli) ]

By  

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2022-2022

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: New Perspectives in the Treatment of Hematological Malignancies (Guest Editor: Masahiro Kizaki)]

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 5, 2006-01 ,pp. : 313-313

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic:Strategies for Molecular-Based Treatment of Hematological Malignancies (Guest Editor: Per Ole Iversen)]

By  

Current Drug Targets, Vol. 6, Iss. 6, 2005-09 ,pp. : 629-629

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [Hot Topic: Interferon Alpha2 in the Treatment of Hematological Malignancies. Status and Perspectives (Guest Editor: Hans Carl Hasselbalch)]

By  

Current Drug Targets, Vol. 12, Iss. 3, 2011-03 ,pp. : 387-391

Bentham Science Publishers

Access to resources Recommend Favorite